Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound
The dense extracellular matrix (ECM) in heterogeneous tumor tissues can prevent the deep tumor penetration of drug-loaded nanoparticles, resulting in a limited therapeutic efficacy in cancer treatment. Herein, we suggest that the deep tumor penetration of doxorubicin (DOX)-loaded glycol chitosan nan...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-10-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/12/10/974 |
| _version_ | 1797550796399706112 |
|---|---|
| author | Yongwhan Choi Hyounkoo Han Sangmin Jeon Hong Yeol Yoon Hyuncheol Kim Ick Chan Kwon Kwangmeyung Kim |
| author_facet | Yongwhan Choi Hyounkoo Han Sangmin Jeon Hong Yeol Yoon Hyuncheol Kim Ick Chan Kwon Kwangmeyung Kim |
| author_sort | Yongwhan Choi |
| collection | DOAJ |
| description | The dense extracellular matrix (ECM) in heterogeneous tumor tissues can prevent the deep tumor penetration of drug-loaded nanoparticles, resulting in a limited therapeutic efficacy in cancer treatment. Herein, we suggest that the deep tumor penetration of doxorubicin (DOX)-loaded glycol chitosan nanoparticles (CNPs) can be improved using high-intensity focused ultrasound (HIFU) technology. Firstly, we prepared amphiphilic glycol chitosan-5β-cholanic acid conjugates that can self-assemble to form stable nanoparticles with an average of 283.7 ± 5.3 nm. Next, the anticancer drug DOX was simply loaded into the CNPs via a dialysis method. DOX-loaded CNPs (DOX-CNPs) had stable nanoparticle structures with an average size of 265.9 ± 35.5 nm in aqueous condition. In cultured cells, HIFU-treated DOX-CNPs showed rapid drug release and enhanced cellular uptake in A549 cells, resulting in increased cytotoxicity, compared to untreated DOX-CNPs. In ECM-rich A549 tumor-bearing mice, the tumor-targeting efficacy of intravenously injected DOX-CNPs with HIFU treatment was 1.84 times higher than that of untreated DOX-CNPs. Furthermore, the deep tumor penetration of HIFU-treated DOX-CNPs was clearly observed at targeted tumor tissues, due to the destruction of the ECM structure via HIFU treatment. Finally, HIFU-treated DOX-CNPs greatly increased the therapeutic efficacy at ECM-rich A549 tumor-bearing mice, compared to free DOX and untreated DOX-CNPs. This deep penetration of drug-loaded nanoparticles via HIFU treatment is a promising strategy to treat heterogeneous tumors with dense ECM structures. |
| first_indexed | 2024-03-10T15:35:34Z |
| format | Article |
| id | doaj.art-6d8d971bfa6442269cf85663aec57061 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T15:35:34Z |
| publishDate | 2020-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-6d8d971bfa6442269cf85663aec570612023-11-20T17:16:31ZengMDPI AGPharmaceutics1999-49232020-10-01121097410.3390/pharmaceutics12100974Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused UltrasoundYongwhan Choi0Hyounkoo Han1Sangmin Jeon2Hong Yeol Yoon3Hyuncheol Kim4Ick Chan Kwon5Kwangmeyung Kim6KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, KoreaCenter for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, KoreaCenter for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, KoreaCenter for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, KoreaDepartment of Chemical & Biomolecular Engineering, Sogang University, Shinsu-dong, Mapo-gu, Seoul 121-742, KoreaKU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, KoreaKU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, KoreaThe dense extracellular matrix (ECM) in heterogeneous tumor tissues can prevent the deep tumor penetration of drug-loaded nanoparticles, resulting in a limited therapeutic efficacy in cancer treatment. Herein, we suggest that the deep tumor penetration of doxorubicin (DOX)-loaded glycol chitosan nanoparticles (CNPs) can be improved using high-intensity focused ultrasound (HIFU) technology. Firstly, we prepared amphiphilic glycol chitosan-5β-cholanic acid conjugates that can self-assemble to form stable nanoparticles with an average of 283.7 ± 5.3 nm. Next, the anticancer drug DOX was simply loaded into the CNPs via a dialysis method. DOX-loaded CNPs (DOX-CNPs) had stable nanoparticle structures with an average size of 265.9 ± 35.5 nm in aqueous condition. In cultured cells, HIFU-treated DOX-CNPs showed rapid drug release and enhanced cellular uptake in A549 cells, resulting in increased cytotoxicity, compared to untreated DOX-CNPs. In ECM-rich A549 tumor-bearing mice, the tumor-targeting efficacy of intravenously injected DOX-CNPs with HIFU treatment was 1.84 times higher than that of untreated DOX-CNPs. Furthermore, the deep tumor penetration of HIFU-treated DOX-CNPs was clearly observed at targeted tumor tissues, due to the destruction of the ECM structure via HIFU treatment. Finally, HIFU-treated DOX-CNPs greatly increased the therapeutic efficacy at ECM-rich A549 tumor-bearing mice, compared to free DOX and untreated DOX-CNPs. This deep penetration of drug-loaded nanoparticles via HIFU treatment is a promising strategy to treat heterogeneous tumors with dense ECM structures.https://www.mdpi.com/1999-4923/12/10/974glycol chitosan nanoparticlehigh-intensity focused ultrasounddeep tumor penetrationdense ECMcancer treatment |
| spellingShingle | Yongwhan Choi Hyounkoo Han Sangmin Jeon Hong Yeol Yoon Hyuncheol Kim Ick Chan Kwon Kwangmeyung Kim Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound Pharmaceutics glycol chitosan nanoparticle high-intensity focused ultrasound deep tumor penetration dense ECM cancer treatment |
| title | Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound |
| title_full | Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound |
| title_fullStr | Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound |
| title_full_unstemmed | Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound |
| title_short | Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound |
| title_sort | deep tumor penetration of doxorubicin loaded glycol chitosan nanoparticles using high intensity focused ultrasound |
| topic | glycol chitosan nanoparticle high-intensity focused ultrasound deep tumor penetration dense ECM cancer treatment |
| url | https://www.mdpi.com/1999-4923/12/10/974 |
| work_keys_str_mv | AT yongwhanchoi deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound AT hyounkoohan deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound AT sangminjeon deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound AT hongyeolyoon deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound AT hyuncheolkim deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound AT ickchankwon deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound AT kwangmeyungkim deeptumorpenetrationofdoxorubicinloadedglycolchitosannanoparticlesusinghighintensityfocusedultrasound |